Back to search
FDAFDA · Food and drugs·Recall number D-1381-2012

Endocet (oxycodone and acetaminophen) tablets, USP, 10 mg/650 mg, 100-count tablets per bottle, Rx only, Manufactured for: Endo Pharmaceuticals Inc., Chadds Ford, PA, By: Novartis, Lincoln, NE 68501; NDC 60951-797-70.

Published June 20, 2012 · Recall initiated: May 7, 2012

Summary

FDA records drug Class III recall D-1381-2012, published June 20, 2012 and initiated May 7, 2012. Recalling firm: Endo Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 11,764 bottles; Lot: Lot #: 402794NV, Exp 12/13. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Adulterated Presence of Foreign Tablets: Customer complaint that some Endocet 10 mg/325 mg tablets were found mixed in a bottle with Endocet 10 mg/650 mg tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Endo Pharmaceuticals, Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot #: 402794NV, Exp 12/13
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Endocet (oxycodone and acetaminophen) tablets, USP, 10 mg/650 mg, 100-count tablets per bottle, Rx only, Manufactured for: Endo Pharmaceuticals Inc., Chadds Ford, PA, By: Novartis, Lincoln, NE 68501; NDC 60951-797-70. recalled?

Yes. FDA published recall D-1381-2012 on June 20, 2012. Reported hazard: Adulterated Presence of Foreign Tablets: Customer complaint that some Endocet 10 mg/325 mg tablets were found mixed in a bottle with Endocet 10 mg/650 mg tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter